CT-2168

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameCT-2168
Drug Alias NameCT-2168
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSigma-2 receptor modulators
TargetsSigma-2 receptor
Therapy Area/IndicationsDementiaParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCognition Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesCognition Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsDementiaParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A